Distribution of gemcitabine pathway genotypes in ethnic Asians and their association with outcome in non-small cell lung cancer patients.
about
Pharmacokinetics and pharmacogenetics of Gemcitabine as a mainstay in adult and pediatric oncology: an EORTC-PAMM perspectivePharmGKB summary: gemcitabine pathwayGenetic factors affecting drug disposition in Asian cancer patients.Clinical and pharmacogenomic implications of genetic variation in a Southern Ethiopian population.Novel SNP improves differential survivability and mortality in non-small cell lung cancer patientsClinical pharmacology and pharmacogenetics of gemcitabine.Gemcitabine metabolic pathway genetic polymorphisms and response in patients with non-small cell lung cancer.Incidence of Febrile Neutropenia in Korean Female Breast Cancer Patients Receiving Preoperative or Postoperative Doxorubicin/Cyclophosphamide Followed by Docetaxel Chemotherapy.Uptake carriers and oncology drug safety.Drug transporter pharmacogenetics in nucleoside-based therapies.Germline genetic markers for urinary bladder cancer risk, prognosis and treatment response.Ethnic differences in the metabolism, toxicology and efficacy of three anticancer drugs.Pharmacogenetics of conventional chemotherapy in non-small-cell lung cancer: a changing landscape?Role of solute carrier transporters in pancreatic cancer: a review.Role of cytidine deaminase in toxicity and efficacy of nucleosidic analogs.Gene polymorphisms, pharmacokinetics, and hematological toxicity in advanced non-small-cell lung cancer patients receiving cisplatin/gemcitabine.Impact of Polymorphic Variations of Gemcitabine Metabolism, DNA Damage Repair, and Drug-Resistance Genes on the Effect of High-Dose Chemotherapy for Relapsed or Refractory Lymphoid Malignancies.Genetic variation in human drug-related genes.Pharmacogenomic diversity in Singaporean populations and Europeans.Association of novel gene polymorphisms RRM1 -756T>C and -269 C>A with breast cancer.Effect of genetic polymorphisms on therapeutic response and clinical outcomes in pancreatic cancer patients treated with gemcitabine.Pathway-based pharmacogenomics of gemcitabine pharmacokinetics in patients with solid tumors.Discovering novel SNPs that are correlated with patient outcome in a Singaporean cancer patient cohort treated with gemcitabine-based chemotherapy.[Advances of drug resistance marker of gemcitabine for non-small cell lung cancer].
P2860
Q26752368-0C695B18-C84B-4708-8B27-182E223A994FQ34435450-E566C02B-0041-4D25-AEE6-34A918D743D5Q34501025-0D09D5B8-8FF1-4461-9154-5CEF9A47C9C6Q34778035-70BDBCF9-F82B-4023-A305-689E1AD04C60Q34913043-834382F3-4B62-481D-961E-5E1EA18EA351Q34985979-5784E3A7-9564-43A9-9603-5D7E07021896Q35675274-CA1E722E-827A-4F06-A64D-6BA398CD094FQ36769011-19349CC3-DEF9-433D-94F1-BA2E36415DE6Q37663396-BFB92553-85CE-46D8-A87E-CFD7497327D4Q37760954-996663FA-F304-4DB3-A72D-911CC0151DF4Q37797468-3D2F6BBD-0B53-426F-8674-6B20F536ECCAQ37876401-4F900D19-6F84-4527-AF7D-D89A2E251CF9Q38030053-CE001100-8D88-4FAA-9386-03200E95FFBCQ38236028-35EEF70F-2D29-4BAC-A57F-6AF6DB249868Q38286242-231DADEE-12D5-4151-A31C-7DAC4D874CF9Q42734042-39209EF5-B5F8-44A5-AE0D-722DF5CFFF3CQ47102782-BA4A7C68-C623-48B7-A9EA-9B8046C0C69BQ47564586-BA4E6C33-B024-4530-9368-2D04F812104AQ53541756-1C1DA9FC-6055-49E3-841F-0E8BF26F4FDCQ54220808-95E033C5-969D-40F9-8A46-4792476AF937Q54494355-A88ED001-1E44-49F4-AC45-6F6620FF046AQ54494358-0FC00FC5-4B6B-4144-BC57-7182AD2A309FQ55315083-DB34CDD4-3916-4E6D-864E-AEAC8CC577B2Q55425187-019137E2-E115-40F5-A54F-A6FA217E5D8F
P2860
Distribution of gemcitabine pathway genotypes in ethnic Asians and their association with outcome in non-small cell lung cancer patients.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
Distribution of gemcitabine pa ...... all cell lung cancer patients.
@ast
Distribution of gemcitabine pa ...... all cell lung cancer patients.
@en
type
label
Distribution of gemcitabine pa ...... all cell lung cancer patients.
@ast
Distribution of gemcitabine pa ...... all cell lung cancer patients.
@en
prefLabel
Distribution of gemcitabine pa ...... all cell lung cancer patients.
@ast
Distribution of gemcitabine pa ...... all cell lung cancer patients.
@en
P2093
P1433
P1476
Distribution of gemcitabine pa ...... all cell lung cancer patients.
@en
P2093
Boon Cher Goh
How Sung Lee
Jian Jun Liu
Lai San Tham
Ling Zhi Wang
Pei Yi Chong
Ross A Soo
Soo Chin Lee
Swee Siang Ng
Tai Bee Choo
P304
P356
10.1016/J.LUNGCAN.2008.04.010
P50
P577
2008-06-05T00:00:00Z